Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Titel:
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Auteur:
Kudo, Masatoshi Finn, Richard S Qin, Shukui Han, Kwang-Hyub Ikeda, Kenji Piscaglia, Fabio Baron, Ari Park, Joong-Won Han, Guohong Jassem, Jacek Blanc, Jean Frederic Vogel, Arndt Komov, Dmitry Evans, T R Jeffry Lopez, Carlos Dutcus, Corina Guo, Matthew Saito, Kenichi Kraljevic, Silvija Tamai, Toshiyuki Ren, Min Cheng, Ann-Lii